Anthropic’s blockbuster IPO: Can AI’s mega bet outrun its biggest risks?

Anthropic’s proposed stock market debut is putting two sides of the artificial intelligence (AI) boom under scrutiny: the enormous commercial opportunity offered by generative AI and the potentially catastrophic risks posed by increasingly powerful systems.

The Claude maker publicly filed its registration statement with the US Securities and Exchange Commission (SEC) on October 26, seeking a Nasdaq listing under the ticker symbol ANT. The offering price and number of shares remain undisclosed, while market reports have placed its potential valuation at between $1.5 trillion and $2 trillion.

Anthropic reported revenue of $16.3 billion in the first half of 2026, up sharply from approximately $1.2 billion in the same period a year earlier. However, it also recorded a net loss of $80.7 billion, of which $72.4 billion was attributed to non-cash accounting adjustments linked to financial instruments.

The distinction matters. The company’s first-half operating loss was $693 million—considerably smaller than its headline net loss—although it still underscores the cost of developing and commercialising advanced AI.

From an investor’s perspective, the central question is whether Anthropic can convert rapid revenue growth into sustainable profitability. Its future computing commitments, dependence on major customers and intense competition from OpenAI and Google DeepMind could complicate that path.

Industry analysts will also be watching whether enterprise demand for Claude remains strong enough to justify the capital required to train, develop and operate increasingly sophisticated models. A multitrillion-dollar valuation would leave little room for disappointing growth or a prolonged delay in achieving profitability.

Recently, Anthropic co-founder and CEO Dario Amodei explained the financial stakes in a podcast: “If my revenue is not $1 trillion, even $800 billion, there’s no force on earth, no hedge on earth, that could stop me from going bankrupt.”

These financial risks are accompanied by a more fundamental concern: the possibility that advanced AI systems could cause serious harm.

Anthropic’s prospectus warns that its models may behave in unintended or autonomous ways, take harmful actions without explicit instructions or be misused by malicious actors. It also acknowledges that their capabilities could advance faster than the company’s ability to assess and mitigate the associated risks.

These warnings carry particular weight because Anthropic has positioned AI safety as central to its mission. Amodei has also called for a more measured approach to frontier AI development, including independent safety evaluations, common standards and international coordination.

The debate has divided technology leaders. While Sam Altman, Elon Musk and Demis Hassabis have supported aspects of stronger coordination or safer development, Meta CEO Mark Zuckerberg has favoured market-led approaches to safety. Nvidia CEO Jensen Huang has argued against additional AI-specific regulation.

For investors, the question extends beyond revenue and earnings. A serious AI safety failure could trigger litigation, regulatory intervention, reputational damage and restrictions on deployment. Conversely, delaying releases or imposing stronger safeguards could increase costs and weaken competitiveness.

Anthropic’s public-benefit corporate structure is designed to balance shareholder interests with its broader mission. However, maintaining that balance could become more difficult under public-market pressure.

The ultimate test for Anthropic is whether it can deliver commercial returns without allowing the race to build more powerful AI systems to outpace meaningful safety measures. Its IPO could reveal how much risk investors, regulators and society are willing to accept in pursuit of AI-driven growth.